Louis Chen
Stock Analyst at Scotiabank
(0.11)
# 4,472
Out of 5,170 analysts
11
Total ratings
18.18%
Success rate
-43.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Louis Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GILD Gilead Sciences | Maintains: Sector Outperform | $140 → $177 | $141.11 | +25.43% | 2 | Feb 11, 2026 | |
| CATX Perspective Therapeutics | Reiterates: Overweight | n/a | $4.60 | - | 8 | Sep 10, 2024 | |
| PCVX Vaxcyte | Reiterates: Overweight | $55 | $53.98 | +1.89% | 1 | Feb 24, 2022 |
Gilead Sciences
Feb 11, 2026
Maintains: Sector Outperform
Price Target: $140 → $177
Current: $141.11
Upside: +25.43%
Perspective Therapeutics
Sep 10, 2024
Reiterates: Overweight
Price Target: n/a
Current: $4.60
Upside: -
Vaxcyte
Feb 24, 2022
Reiterates: Overweight
Price Target: $55
Current: $53.98
Upside: +1.89%